Royal Wuxi Bio-Pharmaceutical

Royal (Wuxi) Bio-Pharmaceutical Co., Ltd. is a specialized pharmaceutical manufacturer located in Wuxi, China, that focuses on the production of heparin and low molecular weight heparin (LMWH) products. As a subsidiary of Hebei Changshan Biochemical Pharmaceutical Co., Ltd., the company is a major global supplier of Enoxaparin Sodium, both as an active pharmaceutical ingredient (API) and in finished injectable forms. The facility is designed to meet international regulatory standards, having received certifications from the US FDA and European authorities. Royal Wuxi plays a critical role in the parent company's international expansion strategy, providing high-quality anticoagulants to markets in Europe, North America, and beyond. The company's operations encompass the entire production chain from crude heparin processing to final fill-finish. Its commitment to quality and compliance has established it as a reliable partner in the global cardiovascular and hematology therapeutic sectors.